[Treatment of acute refractory lymphoblastic leukemia in the adult with VM-26 and ARA-C].
D000293:Adolescent; D000328:Adult; D002648:Child; D003561:Cytarabine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D013713:Teniposide / Q000627:therapeutic use*
D003561:Cytarabine; D013713:Teniposide; D011034:Podophyllotoxin
Tratamiento de la LAL resistente del adulto con VM-26 + ARA-C.